Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

20.73

-0.86 (-3.98%)

At close: Feb 21, 2025, 4:00 PM

20.95

+0.22 (1.06%)

After-hours: Feb 21, 2025, 7:24 PM EST

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $2.98 billion as of February 21, 2025. Its market cap has increased by 29.82% in one year.

Market Cap

2.98B

Enterprise Value

1.75B

1-Year Change

29.82%

Ranking

#1666

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $2.98B, an increase of 58.09%. That is a compound annual growth rate of 6.56%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	2.98B	1.72%
Dec 31, 2024	2.93B	-1.10%
Dec 29, 2023	2.97B	-21.48%
Dec 30, 2022	3.78B	-30.66%
Dec 31, 2021	5.45B	-45.77%
Dec 31, 2020	10.04B	500.43%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	780.72B
UnitedHealth Group	470.30B
Johnson & Johnson	380.14B
Novo Nordisk	370.06B
AbbVie	348.39B
Abbott Laboratories	229.17B
AstraZeneca	228.16B
Intuitive Surgical	217.02B

Market Cap Rankings